Keyphrases
3D Organoids
20%
Agent Efficacy
12%
Brain Cells
20%
Brain Development
20%
Brain Organoids
40%
Brain Tumor
20%
Brain Tumor Model
20%
CD155
100%
Cellular Origin
20%
Culture Conditions
20%
Efficacy Testing
12%
Embryonal Brain Tumor
20%
Ependymoma
20%
Family Interaction
12%
Genetic Engineering
20%
Genetic Manipulation
20%
High-throughput Drug Screen
20%
Human Patients
20%
Human Pluripotent Stem Cells (hPSCs)
20%
Immune Cells
20%
In Vitro Model
20%
Large Series
20%
Medulloblastoma
20%
Molecular Characteristics
20%
Molecular Characterization
20%
Mouse Brain
20%
Navitoclax
37%
Novel Subtype
20%
Oncodrivers
20%
Organoid Models
20%
Organoid Technology
100%
Organoids
40%
Patient Samples
40%
Patient-derived Xenograft
20%
PD-1 Immune Checkpoint
100%
Pediatric Brain Tumor
100%
Preclinical in Vitro Models
20%
Preclinical Modeling
100%
Sampling Methods
20%
Single-cell Transcriptome Analysis
20%
Translational Research
20%
Tumor
80%
Tumor Biology
20%
Tumor Cells
20%
Tumor Organoids
20%
Tumor Subtype
60%
Tumor Tissue
20%
Type-specific
20%
Viable Tissue
20%
Xenograft
20%
Medicine and Dentistry
Brain Cell
11%
Ependymoma
11%
Family Interaction
11%
Gene Expression Profiling
11%
Genetic Screen
11%
Human Pluripotent Stem Cell
11%
Immunocompetent Cell
11%
In Vitro
44%
Intracranial Tumor
33%
Medulloblastoma
11%
Natural Killer Cell Mediated Cytotoxicity
100%
Neoplasm
77%
Nervous System
11%
Organoid
100%
Pediatric Brain Tumor
100%
Tiragolumab
6%
Translational Research
11%
Tumor Biology
11%
Tumor Cell
11%
Tumor Model
11%
Xenograft
22%
Neuroscience
CD155
100%
Durvalumab
5%
Ependymoma
20%
In Vitro
80%
Intracranial Tumor
60%
Medulloblastoma
20%
Natural Killer Cell Mediated Cytotoxicity
100%
Pediatric Brain Tumor
100%
Stem Cell
20%
Tiragolumab
5%
Transcriptomics
20%
